We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.69B
AUM Growth
+$36.1M
Cap. Flow
-$74.5M
Cap. Flow %
-4.4%
Top 10 Hldgs %
46.67%
Holding
141
New
4
Increased
51
Reduced
46
Closed
6

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$8.31M
2
MHO icon
M/I Homes
MHO
+$3.55M
3
CRM icon
Salesforce
CRM
+$2.8M
4
TMHC icon
Taylor Morrison
TMHC
+$2.23M
5
COR icon
Cencora
COR
+$1.89M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$24M
2
KLAC icon
KLA
KLAC
+$11M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.9M
4
AAPL icon
Apple
AAPL
+$9.97M
5
HPQ icon
HP
HPQ
+$7.7M

Sector Composition

Rank Sector Weight
1 Technology 39.09%
2 Communication Services 15.19%
3 Consumer Discretionary 14.55%
4 Healthcare 13.65%
5 Financials 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
26
Global Payments
GPN
$23B
$20.5M 1.21%
101,692
+10
+0% +$1.99K
ZBH icon
27
Zimmer Biomet
ZBH
$17.8B
$20.3M 1.2%
130,673
+7,046
+6% +$1.09M
ALC icon
28
Alcon
ALC
$32.8B
$18.8M 1.11%
267,399
-42,350
-14% -$3M
NVS icon
29
Novartis
NVS
$297B
$18.5M 1.09%
216,328
-23,099
-10% -$2.07M
LH icon
30
Labcorp
LH
$24.7B
$18.2M 1.08%
83,267
+1,036
+1% +$208K
AKAM icon
31
Akamai
AKAM
$16.4B
$15.4M 0.91%
151,140
CRM icon
32
Salesforce
CRM
$142B
$15.2M 0.9%
71,800
+12,595
+21% +$2.8M
CTSH icon
33
Cognizant
CTSH
$22.3B
$14.9M 0.88%
190,683
+10,758
+6% +$831K
DKNG icon
34
DraftKings
DKNG
$12B
$13.9M 0.82%
226,560
-175
-0.1% -$10.5K
ACN icon
35
Accenture
ACN
$94.3B
$13.2M 0.78%
47,902
+5
+0% +$1.29K
ILMN icon
36
Illumina
ILMN
$28.7B
$13.1M 0.78%
35,077
-3,737
-10% -$1.52M
GNTX icon
37
Gentex
GNTX
$4.88B
$12.1M 0.72%
340,375
-1,605
-0.5% -$57K
NTAP icon
38
NetApp
NTAP
$33.3B
$12.1M 0.72%
166,785
+20
+0% +$1.34K
MCK icon
39
McKesson
MCK
$99.5B
$11.5M 0.68%
58,811
-66
-0.1% -$12K
PFE icon
40
Pfizer
PFE
$141B
$11.4M 0.68%
316,036
-205,047
-39% -$7.28M
PYPL icon
41
PayPal
PYPL
$49.5B
$11M 0.65%
45,346
-69
-0.2% -$17.4K
STT icon
42
State Street
STT
$50.7B
$10.1M 0.6%
119,984
+12,414
+12% +$961K
GILD icon
43
Gilead Sciences
GILD
$162B
$8.93M 0.53%
138,229
+20,289
+17% +$1.31M
MDT icon
44
Medtronic
MDT
$108B
$8.7M 0.51%
73,626
+15
+0% +$1.76K
ISRG icon
45
Intuitive Surgical
ISRG
$128B
$8.68M 0.51%
35,256
+4,446
+14% +$1.12M
CHKP icon
46
Check Point Software Technologies
CHKP
$13.6B
$8.41M 0.5%
75,143
-25,000
-25% -$3.01M
DOX icon
47
Amdocs
DOX
$5.64B
$7.99M 0.47%
113,904
-853
-0.7% -$64.4K
AIZ icon
48
Assurant
AIZ
$13.7B
$6.33M 0.37%
44,620
+270
+0.6% +$36.4K
GSK icon
49
GSK
GSK
$104B
$6.08M 0.36%
136,300
-18,636
-12% -$846K
BNY
50
Bank of New York Mellon
BNY
$107B
$6.07M 0.36%
128,300
-1,225
-0.9% -$53.9K

Similar funds

Oak Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Oak Associates held 141 positions worth $1.69B, up 2.2% from $1.65B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates withdrew a net $74.5M in Q1 2021, closing 6 positions and reducing 46 holdings. Its most notable exit was HP, an estimated $7.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Oak Associates opened a new position in Cencora worth $2.06M.

  • Oak Associates's largest Q1 2021 buy was Cencora: 17,440 shares worth $2.06M.
  • Oak Associates added most to JPMorgan Chase in Q1 2021, an estimated $8.31M increase.
  • Oak Associates's biggest Q1 2021 reduction was Xilinx Inc, cutting an estimated $24M.
  • Oak Associates fully exited HP in Q1 2021, selling an estimated $7.7M.
  • Oak Associates's ten largest holdings make up 47% of its $1.69B portfolio in Q1 2021.
  • Oak Associates opened 4 new positions and closed 6 in Q1 2021.
  • Oak Associates's portfolio value rose 2.2% quarter-over-quarter to $1.69B.

Based on Oak Associates's 13F filing for Q1 2021, filed 13 May 2021.